InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: None

Tuesday, 02/07/2017 9:15:44 AM

Tuesday, February 07, 2017 9:15:44 AM

Post# of 203913
Binjo! Like I said earlier, the word "nominations" in the Jan 27th PR lead me to believe there were two new advisory board nominations. And what a pair $OWCP added! Ms. Miri Sani and Dr. Sharon Rozenblat bring a lot to the party!

Now we have two talented individuals with a depth of knowledge and experience in manufacturing and selling cremes in Europe and the German market specifically, and now we have a huge connection to Asia via contacts in Korea, Singapore and China. This is HUGE! This is beyond HUGE!

The traditional biotech route to riches is an old, tired formula: IPO at $50 a share, and hope for FDA approval before the money runs out.

OWCP has a new business plan. Sale of safe and effective topical cremes, in EU and Asia, to generate revenue to pay for those expensive FDA trials for ingested medications.

The foresight and thoughtfulness of the OWCP executive team is so damn rare!

So, tell anyone who was on the MMJ sidelines, worried about cannabis being a schedule 1 substance, that OWCP is likely going to pursue markets in Asia by marketing a line of cannabis cremes as "herbal" remedies. Win Win!

Where it's legal, it will be an MMJ creme. Where it's not legal, it will be a herbal creme. Boom!

Multiple revenue streams, incoming!!!